Assertio Therapeutics Inc (ASRT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Sales | 106,275 | 229,504 | 311,770 | 380,724 | 455,897 |
| Cost of Goods | 19,872 | 9,505 | 18,476 | 72,598 | 87,414 |
| Gross Profit | 86,403 | 219,999 | 293,294 | 308,126 | 368,483 |
| Operating Expenses | 169,430 | 414,932 | 250,111 | 350,904 | 344,388 |
| Operating Income | -82,155 | -194,428 | 43,659 | -42,180 | 24,509 |
| Interest Expense | 15,926 | 58,389 | 68,881 | 73,552 | 83,719 |
| Other Income | 52,568 | 30,333 | 63,197 | 11,807 | -5,292 |
| Pre-tax Income | -45,513 | -222,484 | 37,975 | -103,925 | -64,502 |
| Income Tax | -17,369 | -5,283 | 1,067 | -1,429 | 24,218 |
| Net Income Continuous | -28,144 | -217,201 | 36,908 | -102,496 | -88,720 |
| Net Income | $-28,144 | $-217,201 | $36,908 | $-102,496 | $-88,720 |
| EPS Basic Total Ops | -16.04 | -184.11 | 34.78 | -97.75 | -86.96 |
| EPS Basic Continuous Ops | -16.10 | -184.20 | 34.70 | -98.03 | -86.80 |
| EPS Diluted Total Ops | -16.04 | -184.11 | 34.18 | -97.75 | -86.96 |
| EPS Diluted Continuous Ops | -16.10 | -184.20 | 34.47 | -98.03 | -86.80 |
| EPS Diluted Before Non-Recurring Items | -16.19 | -184.11 | N/A | N/A | N/A |
| EBITDA(a) | $-50,044 | $-67,718 | $171,962 | $82,737 | $151,557 |